STM Journals Peer-reviewed research from Consortium e-Learning Network

Journal of Industrial Safety Engineering Original Research

Identifying and Mitigating Chemical Hazards Through Hazard Identification and Risk Assessment Using Failure Mode and Effects Analysis (FMEA)

  1. Rohit Bharatkumar Govindbhai Department of safety Engineering, Shiv Kumar Singh Institute of Technology and Science, Indore, Madhya Pradesh, India
  2. Pravin Tathod Department of safety Engineering, Shiv Kumar Singh Institute of Technology and Science, Indore, Madhya Pradesh, India

Abstract

Chemical exposure represents a significant occupational health and safety concern in the chemical industry. Effectively addressing these hazards requires teamwork among various occupational health and safety experts, such as general OHS professionals, occupational hygienists, and occupational health practitioners. This research focuses on analyzing hazards and developing control measures for industrial chemicals, evaluating their toxicity, and using these assessments in regulatory decision making. It starts by addressing the availability of toxicological data and the process of hazard identification. Next, it delves into risk assessment and occupational exposure limits. The study also examines specific toxicological issues with unresolved scientific consensus. It provides a historical context of chemical reactivity and toxicity, explores both acute and chronic exposure, and outlines chemical hazard classification systems. Additionally, it details the procedures for identifying, assessing, and managing chemical hazards.

Keywords

References (76)

  1. Antai I, Mutshinda CM. Health status assessment using reverse supply chain data. Manag Res Rev.
  2. 2010;33:111–22. doi:10.1108/01409171011015801.
  3. Barber BM, Odean T. All that glitters: The effect of attention and news on the buying behavior of
  4. individual and institutional investors. Rev Financ Stud. 2008;21:785–818. DOI:
  5. 1093/rfs/hhm079.
  6. Berman B. Strategies to detect and reduce counterfeiting activity. Bus Horiz. 2008;51:191–9. DOI:
  7. 1016/j.bushor.2008.01.002.
  8. Cheah ET, Chan WL, Chieng CLL. The corporate social responsibility of pharmaceutical product
  9. recalls: An empirical examination of U.S. and U.K. markets. J Bus Ethics. 2007;76:427–49. DOI:
  10. 1007/s10551-006-9292-1.
  11. Dickinson JG. Most recalls due to FDA inspection findings. Med Mark Media. 2001;36(5):30.
  12. Fortune. World's most admired companies: How conduct the most admired survey [online]. 2017.
  13. Available from: https://beta.fortune.com/worlds-most-admired-companies/
  14. Harris V, Hart D, Hibbard B, Jurgensen J, Wells J. Crisis communication strategies [online]. The
  15. University of Oklahoma Department of Defense Communication Course; 2002. Available from:
  16. https://www.ou.edu/deptcomm/dodjcc/groups/02C2/Johnson%20&%20Johnson.html
  17. Horvath PA, Autry C, Wilcox W. Liquidity implications of reverse logistics for retailers: A Markov
  18. chain approach. J Retail. 2005;81:191–203. doi:10.1016/j.jretai.2005.07.003.
  19. Mollah H, Baseman H, Long M. Risk management applications in pharmaceutical and
  20. biopharmaceutical manufacturing. John Wiley & Sons: NJ, USA; 2013.
  21. Mukharya A, Patel PU, Shenoy D, Chaudhary S. Quality risk management of top spray fluidized
  22. bed process for antihypertensive drug formulation with control strategy engendered by Boxbehnken experimental design space. Int J Pharm Investig. 2013;3:15–28. doi:10.4103/2230-
  23. 973X.108960. PubMed: 23799202.
  24. Nayak VS, Khan MS, Shukla BKS. Quality management in risk-based monitoring. Int J Clin Trials.
  25. 2016;3:59–63. doi:10.18203/2349-3259.ijct20161412.
  26. Noordhuizen JPTM. Applying HACCP-based quality risk management on dairy farms.
  27. Wageningen Academic: Wageningen, The Netherlands; 2008.
  28. Nosal R, Schultz T. PQLI definition of criticality. J Pharm Innov. 2008;3:69–78. DOI:
  29. 1007/s12247-008-9033-3.
  30. O'Donnell K, Greene A. Failure modes: Simple strategies for improving qualitative quality risk
  31. management exercises during qualification, validation, and change control activities. J Valid
  32. Technol. 2007;13:100–12.
  33. Qing L, Rengkui L, Jun Z, Quanxin S. Quality risk management model for railway construction
  34. projects. Procedia Eng. 2014;84:195–203. doi:10.1016/j.proeng.2014.10.426.
  35. Zeng T, Chen G, Yang Y, Reniers G, Zhao Y, Liu X. A systematic literature review on safety
  36. research related to chemical industrial parks. Sustainability. 2020;12:5753. DOI:
  37. 3390/su12145753.
  38. Fairhurst S. Hazard and risk assessment of industrial chemicals in the occupational context in
  39. Europe: Some current issues. Food Chem Toxicol. 2003;41:1453–62. doi:10.1016/s0278-
  40. 6915(03)00193-5. PubMed: 12962997.
  41. Kozine I, Duijm NJ, Lauridsen K. Safety- and risk analysis activities in chemical industry in
  42. Europe. In: Andersson K, editor. VALDOR Symposium Addressing Transparency in Risk
  43. Assessment and Decision Making; 1975 June 10-14; Stockholm. 8-12.
  44. Leggett DJ. Lab-HIRA: Hazard identification and risk analysis for the chemical research laboratory.
  45. Part 2. Risk analysis of laboratory operations. J Chem Health Saf. 2012;19:25–36. DOI:
  46. 1016/j.jchas.2012.01.013.
  47. Paithankar A. Hazard identification and risk analysis in the mining industry [dissertation].
  48. Rourkela, India: National Institute of Technology; 2011.
  49. Ashokkumar TC, Muthukumar K, Manojkumar RM. Hazard identification and risk assessment
  50. (HIRA) in textile industry. Int Res J Eng Technol. 2020;7(3):3172–80.
  51. Bhusnure OG, Dongare RB, Gholve SB, Giram PS. Chemical hazards and safety management in
  52. pharmaceutical industry. J Pharm Res. 2018;12(3):523–9.
  53. Hafeez A, Ahmad S, Kamboj A, Ahmad M, Al-Taie A, Siddiqui SA, et al. Industrial hazards and
  54. safety management in pharmaceutical industry. Int J Appl Res. 2020;6(5):1–7.
  55. Alhasadi RT. Industrial hazards and safety measures in pharmaceutical industries. Int J Sci Res.
  56. 2018;9(2):856–60. doi:10.21275/ART20204410.
  57. Fung VSWC. Risk assessment and communication in pharmaceuticals: Recognizing the differences
  58. in occupational health and medication safety. J Toxicol Risk Assess. 2019;5:019. DOI:
  59. 23937/2572-4061.1510019.
  60. Sangshetti JN, Deshpande M, Zaheer Z, Shinde DB, Arote R. Quality by design approach:
  61. Regulatory need. Arab J Chem. 2017;10–S3425. doi:10.1016/j.arabjc.2014.01.025.
  62. Sivadasu S, Gangadharappa HV, Kiran HC, Jose A. Quality risk management: A review. Int J
  63. Pharm Sci Rev Res. 2017;44:142–8.
  64. Mahaparale SG, Kuchekar M, Walase S. A review: Quality risk management methods and their
  65. potential applications. Int J Appl Pharm Biol Res. 2016;1:47–66.
  66. Staniec I. Factors that determine the functioning of risk management systems. Int Proc Econ Dev
  67. Res. 2011;22:87–91.
  68. Tsiga Z, Emes M, Smith A. Implementation of a risk management simulation tool. Procedia Comput
  69. Sci. 2017;121:218–23. doi:10.1016/j.procs.2017.11.030.
  70. Vesper J, O'Donnell K. Current challenges in implementing quality risk management. Pharm Eng.
  71. 2016;36:73–4.
  72. Vincent DW, Honeck W. Risk management analysis techniques for validation programs. J Valid
  73. Technol. 2004;10:235–51.
  74. Waldron K. Managing risk to the patient: Recoding quality risk management for the pharmaceutical
  75. and biopharmaceutical industries. [Doctoral Thesis]. Dublin, Ireland: Dublin Institute of
  76. Technology; 2017
Support